209
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Preparation and antitumor activity of bFGF-mediated active targeting doxorubicin microbubbles

, , , , , , , , , , , , , , & show all
Pages 1712-1719 | Received 17 May 2012, Accepted 11 Sep 2012, Published online: 15 Oct 2012

References

  • Husseini GA, Pitt WG. (2008). The use of ultrasound and micelles in cancer treatment. J Nanosci Nanotechnol, 8:2205–2215.
  • Lu CT, Zhao YZ, Wu Y, Tian XQ, Li WF, Huang PT et al. (2011). Experiment on enhancing antitumor effect of intravenous epirubicin hydrochloride by acoustic cavitation in situ combined with phospholipid-based microbubbles. Cancer Chemother Pharmacol, 68:343–348.
  • Huang SL, MacDonald RC. (2004). Acoustically active liposomes for drug encapsulation and ultrasound-triggered release. Biochim Biophys Acta, 1665(1–2):134–141.
  • Suzuki R, Takizawa T, Negishi Y, Utoguchi N, Maruyama K. (2008). Effective gene delivery with novel liposomal bubbles and ultrasonic destruction technology. Int J Pharm, 354(1–2):49–55.
  • Shortencarier MJ, Dayton PA, Bloch SH, Schumann PA, Matsunaga TO, Ferrara KW. (2004). A method for radiation-force localized drug delivery using gas-filled lipospheres. IEEE Trans Ultrason Ferroelectr Freq Control, 51(7):822–831.
  • Myhr G, Moan J. (2006). Synergistic and tumour selective effects of chemotherapy and ultrasound treatment. Cancer Lett, 232:206–213.
  • Rosenthal I, Sostaric JZ, Riesz P. (2004). Sonodynamic therapy–a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem, 11:349–363.
  • Schroeder A, Avnir Y, Weisman S, Najajreh Y, Gabizon A, Talmon Y et al. (2007). Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility. Langmuir, 23:4019–4025.
  • Gao Z, Kennedy AM, Christensen DA, Rapoport NY. (2008). Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics, 48:260–270.
  • Tartis MS, McCallan J, Lum AF, LaBell R, Stieger SM, Matsunaga TO et al. (2006). Therapeutic effects of paclitaxel-containing ultrasound contrast agents. Ultrasound Med Biol, 32:1771–1780.
  • Duncan R, Gac-Breton S, Keane R, Musila R, Sat YN, Satchi R et al. (2001). Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic. J Control Release, 74:135–146.
  • Zhao YZ, Sun CZ, Lu CT, Dai DD, Lv HF, Wu Y et al. (2011). Characterization and anti-tumor activity of chemical conjugation of doxorubicin in polymeric micelles (DOX-P) in vitro. Cancer Lett, 311:187–194.
  • Fischer B, Marinov M, Arcaro A. (2007). Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): what have we learned so far? Cancer Treat Rev, 33:391–406.
  • Burgess WH, Maciag T. (1989). The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem, 58:575–606.
  • Klagsbrun M. (1989). The fibroblast growth factor family: structural and biological properties. Prog Growth Factor Res, 1:207–235.
  • Terada T, Mizobata M, Kawakami S, Yabe Y, Yamashita F, Hashida M. (2006). Basic fibroblast growth factor-binding peptide as a novel targeting ligand of drug carrier to tumor cells. J Drug Target, 14:536–545.
  • Terada T, Mizobata M, Kawakami S, Yamashita F, Hashida M. (2007). Optimization of tumor-selective targeting by basic fibroblast growth factor-binding peptide grafted PEGylated liposomes. J Controlled Release, 119(3):262–270.
  • Böhlen P, Stein S, Dairman W, Udenfriend S. (1973). Fluorometric assay of proteins in the nanogram range. Arch Biochem Biophys, 155:213–220.
  • Zhao YZ, Luo YK, Zhang Y, Mei XG, Tang J. (2005). Property and contrast-enhancement effects of lipid ultrasound contrast agent: a preliminary experimental study. Ultrasound Med Biol, 31(4):537–543.
  • Zhao YZ, Luo YK, Liang HD, Mei XG, Tang J, Lu CT et al. (2006). Comparing transfection efficiency and safety for antisense oligodeoxyribonucleotide between phospholipids-based microbubbles and liposomes. J Drug Target, 14:687–693.
  • Bao S, Thrall BD, Miller DL. (1997). Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med Biol, 23:953–959.
  • Miller DL, Quddus J. (2000). Sonoporation of monolayer cells by diagnostic ultrasound activation of contrast agent gas bodies. Ultrasound Med Biol, 26(4):661–667.
  • Brayman AA, Coppage ML, Vaidya S, Miller MW. (1999). Transient poration and cell surface receptor removal from human lymphocytes in vitro by 1MHz ultrasound. Ultrasound Med Biol, 25(6):999–1008.
  • Miller DL, Dou CY. (2004). Membrane damage thresholds for pulsed or continuous ultrasound in phagocytic cells loaded with contrast agent gas bodies. Ultrasound Med Biol, 30(7):405–411.
  • Zhao YZ, Luo YK, Lu CT, Xu JF, Tang J, Zhang M et al. (2008). Phospholipids-based microbubbles pore sonoporation size and reseal of cell membrane cultured in vitro. J Drug Target, 16(1):18–25.
  • Price RJ, Skyba DM, Kaul S, Skalak TC. (1998). Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation, 98:1264–1267.
  • Vancraeynest D, Havaux X, Pouleur AC, Pasquet A, Gerber B, Beauloye C et al. (2006). Myocardial delivery of colloid nanoparticles using ultrasound-targeted microbubble destruction. Eur Heart J, 27:237–245.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.